ArticleBritish journal of clinical pharmacology2021
Spotlight commentary: A role for real-world evidence to inform the clinical care of patients with diabetes mellitus.
Charles E Leonard, James H Flory, Robert Likić, Olayinka O Ogunleye, Li Wei, Ian Wong
Abstract read
In one paragraphArticle in British journal of clinical pharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
6 authors.
Charles E LeonardPerelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.ORCID 0000-0002-5092-9657 James H FloryDepartment of Subspecialty Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Olayinka O OgunleyeDepartment of Pharmacology, Therapeutics, and Toxicology, Lagos State University College of Medicine, Ikeja, Nigeria.
Li WeiSchool of Pharmacy, University College London, London, UK.
Ian WongSchool of Pharmacy, University College London, London, UK.
Funding
X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4MClinical Importance of Drug-Drug InteractionsR01AG025152 · NIA · UNIVERSITY OF PENNSYLVANIA · PI HENNESSY, SEAN, LI, LANG · 2006 to 2021
$8.1MDrug interactions involving psychoactive drugsR01AG060975 · NIA · UNIVERSITY OF PENNSYLVANIA · PI Charles Edward Leonard · 2019 to 2026
$3.9MDrug-Drug Interactions Involving Methadone and BuprenorphineR01DA048001 · NIDA · UNIVERSITY OF PENNSYLVANIA · PI HENNESSY, SEAN · 2019 to 2023
$2.9MEnhancing the Utility of the Trend-in-Trend Research DesignR01AG064589 · NIA · UNIVERSITY OF PENNSYLVANIA · PI HENNESSY, SEAN, SMALL, DYLAN S · 2019 to 2022
$2.2MHSRD VA I21 HX003273NCI NIH HHS P30 CA008748NCI NIH HHS P30-CA008748NIA NIH HHS R01 AG025152NIA NIH HHS R01-AG025152NIA NIH HHS R01 AG060975NIA NIH HHS R01-AG060975NIA NIH HHS R01 AG064589NIA NIH HHS R01-AG064589NIDA NIH HHS R01 DA048001NIDA NIH HHS R01-DA048001U.S. Department of Veterans Affairs I21-HX003273U.S. Food and Drug Administration HHSF223301710132C
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Diabetes MellitusDiabetes Mellitus, Type 2HumansHypoglycemic AgentsHypoglycemic Agents
Identifiers
PMID33942355
PMCPMC9479484
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390